| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |